Antibodies Market: Future Growth Prospects and Market Dynamics


Key trends and prospects in terms of product type, application, and end user for the next ten years are provided by Fact.MR in their most recent Antobodies Market research.

.

Key trends and prospects in terms of product type, application, and end user for the next ten years are provided by Fact.MR in their most recent Antobodies Market research. The study also focuses on providing distinct market insights to assist big businesses in creating coherent strategies that would provide them a competitive advantage. Fact.MR: A Supplier of Competitive Intelligence and Market Research: Between 2022 and 2032, the global antibody market is expected to increase by double digits at a compound annual growth rate of 11.9%, reaching a valuation of US$ 608 billion by that time. Over the course of the forecast period (2022–2032), the market is expected to be driven by rising investments in research development activities, particularly in the field of vaccine development.

Governments around the world are increasing their grants and funds for the development of vaccines for tackling a range of diseases. Vaccinations and novel therapies have proved to be effective in numerous disease management. Further, growing focus to reduce the global burden of diseases such as Parkinson's, Alzheimer’s, and multiple sclerosis is expected to create opportunities for antibodies market players.
Further, as per World Health Organization, the proportion of global population over 60 years will double from 12% to 22% by 2050. Hence, increasing geriatric population has led to strong focus on management of chronic diseases. For instance, around 21% of elderly in India have at least one chronic disease, as per National Library of Medicine. This is expected to boost the demand for quality antibodies for development of novel therapies in the market.

Get A Sample Copy of this Report!

https://www.factmr.com/connectus/sample?flag=Srep_id=194

Regionally, North America and Europe are predicted to dominate the global antibodies market. However, growing healthcare investments in India and China are likely to create lucrative opportunities for market players in South East Asia during the assessment period.

Key Takeaways:

  • North America's share in the global antibodies market is likely to be 49% in 2032.
  • Europe antibodies market is expected to grow at 11.2% CAGR during 2022-2032.
  • By end-use, demand for antibodies is expected to remain highest in biopharmaceutical companies.
  • By product type, monoclonal antibodies segment is expected to dominate over the forecast period.
  • By application, drug discovery and development is likely to be the most lucrative segment.
  • Sales in China antibodies market are projected to expand at 10% CAGR over the upcoming decade.

Growth Drivers:

  • Increasing emphasis on creating novel therapies for treatment of chronic diseases such as Parkinson’s, and others is anticipated to boost the antibodies market.
  • Emergence of medical tourism centers in South East Asia and Latin America is anticipated to aid the growth.
  • Growing development in biomarker discovery and interest in outsourcing is predicted to create conducive environment for the market.

Restraints:

  • High cost and time-intensive process for development of antibodies might limit the growth in the market, especially in emerging countries.
  • Growing pricing pressure and competitive costs might create a challenge for start-ups.

Get Customization on this Report for Specific Country

https://www.factmr.com/connectus/sample?flag=RCrep_id=194

Competitive Landscape:

Leading players are focusing on tying up with research institutes to gain technical know-how and expertise. Further, leading market players are also focusing on gaining funds from governments and other institutions. Mergers acquisitions are also a key focus area for prominent players.

For instance,

  • In 2021, Thermo Fisher acquired PPD to boost its strength in the clinical research services field.
  • In 2022, Abcam and Twist Bioscience Corporation signed a license agreement for antibody development and research.

Key Companies Profiled by Fact.MR

  • Sanofi SA
  • Eli Lilly and Co.
  • Bristol-Myers Squibb Company
  • AbbVie Inc.
  • Amgen Inc.
  • Biogen Inc.
  • F. Hoffmann-La Roche AG
  • Johnson Johnson
  • Takeda Pharmaceutical Company Limited
  • Novartis AG

More Valuable Insights on Antibodies Market

In its latest study, Fact.MR offers a detailed analysis of the global antibodies market for the forecast period of 2022 to 2032. This study also divulges key drivers and trends promoting the sales of antibodies through detailed segmentation as follows:

By Product Type:

  • Monoclonal
  • Polyclonal
  • Immune Checkpoint
  • Epitope Tag
  • Isotype Control
  • Primary
  • Assay
  • Others

By Application:

  • Drug Discovery Development
  • Basic Research
  • Toxicity Screening
  • Biopharmaceutical Production
  • Drug Screening
  • Tissue Engineering
  • Forensic Testing
  • Others

By End User:

  • Biopharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Academic Research Institutes
  • Forensic Science Laboratories
  • Food Beverage Companies
  • Diagnostic Centers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • APAC
  • MEA

Related Publish by Fact.MR Industry:

Dental Restoratives Market

https://www.factmr.com/report/4725/dental-restoratives-market

Ultrasound Probe Disinfection Market

https://www.factmr.com/report/ultrasound-probe-disinfection-market

Pneumatic Nebulizers Market

https://www.factmr.com/report/pneumatic-nebulizers-market

Huntington's Disease Treatment Market

https://www.factmr.com/report/huntingtons-disease-treatment-market

Comments